Search

People who had a potentially allergic reaction to their first messenger RNA COVID-19 vaccination can safely receive their second shot, according to a study of patients conducted at several medical centers, including UT Southwestern.

Switching what the powerhouses of heart cells consume for energy could help the heart regenerate when cells die.

As more DFW businesses and schools have reopened, and as cases have begun to surge again, researchers are expanding participation for the DFW COVID-19 Prevalence Study – uniquely designed to reveal how widely COVID-19 has spread and why some communities are harder hit.

March of Dimes, a national leader in maternal and infant health research, today announced the launch of the Texas Collaborative Prematurity Research Center (PRC), uniting scientists from The University of Texas Medical Branch (UTMB) at Galveston and UT Southwestern Medical Center in Dallas.

UT Southwestern Simmons Cancer Center researchers have developed technology that is spawning a much better form of drug delivery for gene therapy and has achieved a 43 percent increase in the survival of mice with glioblastoma, one of the deadliest forms of human brain cancer.

A day earlier, a severely ill Nathaniel Jones received a healthy kidney from Sarah Schecter, a principal at his children’s school.

UT Southwestern will lead a multicenter investigation into why children and young adults experience decreased physical activity and shortness of breath after experiencing blood clots, thanks to a four-year $2.97 million grant from the National Institutes of Health (NIH).

Children's HealthSM, the leading pediatric health care provider in North Texas, and UT Southwestern Medical Center announce their first joint pediatric enterprise initiative at the Reimagine RedBird development to broaden access in southern Dallas to the region’s top pediatric care.

The bacteria that cause the deadly lung disease tuberculosis appear to facilitate their own spread by producing a molecule that triggers cough.

An experimental drug that has shown promise in protecting healthy tissue from collateral damage caused by radiation therapy for cancer also appears to enhance radiation’s capacity to kill tumors.